| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 05/07/2009 | WO2009005917A3 Methods of treating measles infectious disease in mammals |
| 05/07/2009 | WO2008157203A3 Methods of protecting animals from avian influenza infection |
| 05/07/2009 | WO2008140577A3 Cd44 pathway antagonists for treatment of adenoviral infection |
| 05/07/2009 | WO2008111943A3 Secreted campylobacter flagella coregulated proteins as immunogens |
| 05/07/2009 | WO2008076278A3 Methods of cancer treatment with igf1r inhibitors |
| 05/07/2009 | WO2008060669A3 Vaccine for avian influenza and methods of use |
| 05/07/2009 | WO2007100357A3 Stem cell factor-like protein scfa1 and uses thereof |
| 05/07/2009 | WO2007061936A3 Clearance of abnormal iga1 in iga1 deposition diseases |
| 05/07/2009 | WO2007044323A3 Fusion proteins for blood-brain barrier delivery |
| 05/07/2009 | WO2007033291A3 Regulatory cd8+t cells induced with anti-cd3 antibody |
| 05/07/2009 | WO2006125202A3 Anti- mcp-1 antibodies, compositions, methods and uses |
| 05/07/2009 | WO2006041890A3 Treatment and prevention of hypersensitivity and/or anaphylaxis with anti-ige antibodies in patients receiving replacement therapy |
| 05/07/2009 | WO2006026358A3 Sperm specific raft associated proteins |
| 05/07/2009 | WO2005112999A3 Cancer treatment with inhibitors of collagen synthesis |
| 05/07/2009 | US20090118486 Uspa1 and uspa2 antigens of moraxella catarrhalis |
| 05/07/2009 | US20090118473 MN Gene and Protein |
| 05/07/2009 | US20090118468 Immunotherapy of prostate, including hormone-refractory prostate cancer (HRPC), and breast cancer; vaccines |
| 05/07/2009 | US20090118219 Flea gaba receptor subunit nucleic acid molecules |
| 05/07/2009 | US20090118171 Use of enzymatic inhibitors of h-prune for the prevention and treatment of the metastases of tumours overexpressing h-prune |
| 05/07/2009 | US20090118170 Buccal, polar and non-polar spray or capsule |
| 05/07/2009 | US20090118141 Methods of oligosaccharide profiling for the detection of ocular rosacea |
| 05/07/2009 | US20090117566 Compositions and methods for the diagnosis and treatment of tumor |
| 05/07/2009 | US20090117193 Compositions Comprising an Active Agent |
| 05/07/2009 | US20090117178 with immunogenic or therapeutic properties against ischemic cardiovascular diseases; atherosclerosis |
| 05/07/2009 | US20090117172 Oral delivery vehicle and material |
| 05/07/2009 | US20090117157 Methods of treating urogenital-neurological disorders using modified clostridial toxins |
| 05/07/2009 | US20090117156 Gene therapy for niemann-pick disease type a |
| 05/07/2009 | US20090117155 Treatment of hiv-1 by modulation of vpr activation of the m-csf promoter |
| 05/07/2009 | US20090117154 Synthetic polyvalent carbohydrates as components of microbicides |
| 05/07/2009 | US20090117153 Disulfide Trap MHC Class I Molecules and Uses Therefor |
| 05/07/2009 | US20090117152 Mycoplasma Hyopneumoniae Avirulent Adjuvanted Live Vaccine |
| 05/07/2009 | US20090117151 for preparing a vaccine which contains one or more than two genes among pgs B, pgs C and pgs A encoding poly- gamma -glutamate synthetase complex and genes selected from human papilloma virus (HPV) E6 and HPV E7 antigen protein associated with tumor induction; genital wash |
| 05/07/2009 | US20090117150 Functional Mutations In Respiratory Syncytial Virus |
| 05/07/2009 | US20090117149 Novel attenuated virus strains and uses thereof |
| 05/07/2009 | US20090117148 Capsular Polysaccharides Solubilisation and Combination Vaccines |
| 05/07/2009 | US20090117147 Vaccines comprising outer membrane vesicles from gram negative bacteria |
| 05/07/2009 | US20090117145 Composition and Method For Enhancing Immune Response |
| 05/07/2009 | US20090117144 Recombinant flu vaccines |
| 05/07/2009 | US20090117143 Recombinant adenylate cyclase toxin of bordetella induces T cell responses against tumoral antigens |
| 05/07/2009 | US20090117142 Recombinant fusobacterium necrophorum leukotoxin vaccine and preparation thereof |
| 05/07/2009 | US20090117141 Hiv vaccine composition |
| 05/07/2009 | US20090117140 Human papilloma virus dominant CD4 T cell epitopes and uses thereof |
| 05/07/2009 | US20090117139 Lutzomyia longipalpis polypeptides and methods of use |
| 05/07/2009 | US20090117138 Vaccine for a therapeutic or a prophylactic treatment of myasthenia gravis |
| 05/07/2009 | US20090117137 Peptide epitopes of apolipoprotein b |
| 05/07/2009 | US20090117136 Recombinant allergen |
| 05/07/2009 | US20090117135 Vaccine comprising an antigen conjugated to low valency anti-cd40 or anti-cd28 antibodies |
| 05/07/2009 | US20090117134 Truncated EGF Receptor |
| 05/07/2009 | US20090117133 POLYMERIC IMMUNOGLOBULIN FUSION PROTEINS THAT TARGET LOW AFFINITY FCyRECEPTORS |
| 05/07/2009 | US20090117132 Anti-Ctla-4 Antibody and Cpg-Motif-Containing Synthetic Oligodeoxynucleotide Combination Therapy for Cancer Treatment |
| 05/07/2009 | US20090117131 Pharmaceutical Composition for The Treatment or Prevention of Allergic Diseases, Use Thereof, and A Method for The Treatment or Prevention of Allergic Diseases |
| 05/07/2009 | US20090117130 Kallikrein-inhibitor therapies |
| 05/07/2009 | US20090117129 Immunogen adherence inhibitor directed to lactobacillus organisms and method of making and using it |
| 05/07/2009 | US20090117128 Anti-HPA |
| 05/07/2009 | US20090117127 Novel Compounds and Methods for Their Production |
| 05/07/2009 | US20090117126 Neutralising Antibody Molecules Having Specificity for Human IL-17 |
| 05/07/2009 | US20090117125 Synthesis of 8h-3a-aza-cyclopenta[a]indenes and 5,10-dihydropyrrolo[1,2-b]isoquinolines derivatives and their use as antitumor therapeutic agents |
| 05/07/2009 | US20090117124 Anti-IgE antibodies |
| 05/07/2009 | US20090117123 Immunopeptides of hpv e6 and e7 proteins |
| 05/07/2009 | US20090117122 Resistin Antagonists and Their Use |
| 05/07/2009 | US20090117121 Pseudomonas Aeruginosa Outer Membrane Protein PA0427 |
| 05/07/2009 | US20090117120 Transgenic animal model for alzheimer's disease |
| 05/07/2009 | US20090117119 Rtef-1 variants and the use thereof for inhibition of angiogenesis |
| 05/07/2009 | US20090117118 Antibodies specific for sclerostin and methods for increasing bone mineralization |
| 05/07/2009 | US20090117117 Targeting abcb5 for cancer therapy |
| 05/07/2009 | US20090117116 Immunogenic peptides and methods of use for treating and preventing cancer |
| 05/07/2009 | US20090117115 Binary epitope antibodies and B cell superantigen immune stimulants |
| 05/07/2009 | US20090117114 IL-17 homologous polypeptides and therapeutic uses thereof |
| 05/07/2009 | US20090117113 Immunogenic And Therapeutic Compositions For Streptococcus Pyogenes |
| 05/07/2009 | US20090117112 Immunomodulatory compositions and uses therefor |
| 05/07/2009 | US20090117111 Uses of anti-cd40 antibodies |
| 05/07/2009 | US20090117110 Method for the In Vitro Assessment of the Progression Status of an Infection by an HIV Virus in an Individual |
| 05/07/2009 | US20090117109 Methods For Reducing Biofilm Formation In Infectious Bacteria |
| 05/07/2009 | US20090117108 Gene Engineering Recombinant Anti-CEA, Anti-CD3, And Anti-CD28 Single-Chain Tri-Specific Antibody |
| 05/07/2009 | US20090117107 Molecular targets and compounds, and methods to identify the same, useful in the treatment of bone and joint degenerative diseases |
| 05/07/2009 | US20090117106 Cancer Specific Glycans and Use Thereof |
| 05/07/2009 | US20090117105 Humanized anti-venezuelan equine encephalitis virus recombinant antibody |
| 05/07/2009 | US20090117104 Glucagon-like peptide-2 (GLP-2); treating inflammatory ileus |
| 05/07/2009 | US20090117103 M-CSF Antibody compositions Having Reduced Levels of Endotoxin |
| 05/07/2009 | US20090117102 Methods and compositions using CD3 agonists |
| 05/07/2009 | US20090117101 HEH4 Molecules and Uses Thereof |
| 05/07/2009 | US20090117100 Cysteine engineered anti-TENB2 antibodies and antibody drug conjugates |
| 05/07/2009 | US20090117099 Extracellular histones as biomarkers for prognosis and molecular targets for therapy |
| 05/07/2009 | US20090117098 Complement C1Q Inhibitors For The Prevention And Treatment Of Glaucoma |
| 05/07/2009 | US20090117097 Stabilizer for Protein Preparation Comprising Meglumine and Use Thereof |
| 05/07/2009 | US20090117096 Methods and compositions for inhibition of metastasis |
| 05/07/2009 | US20090117095 Methods and compositions for diagnosis and treatment of b cell chronic lymphocytic leukemia |
| 05/07/2009 | US20090117083 Immunomodulatory alkaloids |
| 05/07/2009 | US20090117074 Sulfonylpyrroles as Histone Deacetylase Inhibitors |
| 05/07/2009 | US20090117073 Use of a fusion protein targeting the ed-b fibronectin domain for treatment of atherosclerosis |
| 05/07/2009 | US20090117070 Methods and Crosslinked Polymer Compositions for Cartilage Repair |
| 05/07/2009 | US20090117049 Light emitting microorganisms and cells for diagnosis and therapy of tumors |
| 05/07/2009 | US20090117048 Light emitting microorganisms and cells for diagnosis and therapy of tumors |
| 05/07/2009 | US20090117047 Light emitting microorganisms and cells for diagnosis and therapy of tumors |
| 05/07/2009 | US20090117043 Antibodies That Specifically Bind to Neurokinin B |
| 05/07/2009 | US20090117038 Breast Endothelial Cell Expression Patterns |
| 05/07/2009 | US20090117037 Methods Of Treatment Using CTLA-4 Antibodies |
| 05/07/2009 | US20090117036 Antibodies against gpr64 and uses thereof |
| 05/07/2009 | US20090117034 Microorganisms for imaging and/or treatment of tumors |
| 05/07/2009 | CA2805976A1 Immunosuppressive polypeptides and nucleic acids |